Metastatic Urachal Carcinoma Treated With Several Different Combined Regimens: A Case Report

被引：6

作者：

Zheng, Han ^{[1
]}

Song, Wei ^{[1
]}

Feng, Xiemin ^{[1
]}

Zhao, Hong ^{[1
]}

机构：

[1] Yanan Univ, Dept Med Oncol, Affiliated Hosp 1, Yanan, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2021年 / 11卷

关键词：

urachal carcinoma; serum marker; immunity therapy; targeted therapy; combination chemotherapy; ADENOCARCINOMA; MANAGEMENT; FEATURES; CANCER;

D O I：

10.3389/fonc.2021.662589

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Urachal carcinoma is a rare bladder malignance. This study presents a case of an elderly patient with urachal carcinoma who was found to have pulmonary metastases 1 year after 5 recurrent resections. The patient was treated with up to 7 different chemotherapy regimens, including a VEGF monoclonal antibody and anti-PD-1 antibody. This is the first report of PD-1 antibody being used in patients with urachus, although the disease progressed after only four cycles of the application. The patient's disease was controlled by the FOLFIRI combined with the VEGF monoclonal antibody regimen. The most prominent issues at present are the difficulty of obtaining drugs for rare cancers and the lack of late-stage clinical trials to guide therapeutic decisions.

引用

页数：5

共 19 条

[1] Urachal carcinoma: Clinicopathologic features and long-term outcomes of an aggressive malignancy [J].

Ashley, Richard A. ;

Inman, Brant A. ;

Sebo, Thomas J. ;

Leibovich, Bradley C. ;

Blute, Michael L. ;

Kwon, Eugene D. ;

Zincke, Horst .

CANCER, 2006, 107 (04) :712-720

[2]

Begg RC, 1930, J ANAT, V64, P170

[3] Current Understanding of Urachal Adenocarcinoma and Management Strategy [J].

Claps, Melanie ;

Stellato, Marco ;

Zattarin, Emma ;

Mennitto, Alessia ;

Sepe, Pierangela ;

Guadalupi, Valentina ;

Mennitto, Roberta ;

de Braud, Filippo G. M. ;

Verzoni, Elena ;

Procopio, Giuseppe .

CURRENT ONCOLOGY REPORTS, 2020, 22 (01)

[4] CLINICAL-FEATURES OF URACHAL CARCINOMA IN JAPAN - REVIEW OF 157 PATIENTS [J].

GHAZIZADEH, M ;

YAMAMOTO, S ;

KUROKAWA, K .

UROLOGICAL RESEARCH, 1983, 11 (05) :235-238

[5] Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada [J].

Hamilou, Zineb ;

North, Scott ;

Canil, Christina ;

Wood, Lori ;

Hotte, Sebastien ;

Sridhar, Srikala S. ;

Soulieres, Denis ;

Latour, Mathieu ;

Taussky, Daniel ;

Kassouf, Wassim ;

Blais, Normand .

CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (03) :E57-E64

[6] Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype [J].

Kardos, Jordan ;

Wobker, Sara E. ;

Woods, Michael E. ;

Nielsen, Matthew E. ;

Smith, Angela B. ;

Wallen, Eric M. ;

Pruthi, Raj S. ;

Hayward, Michele C. ;

McGinty, Katrina A. ;

Grilley-Olson, Juneko E. ;

Patel, Nirali M. ;

Weck, Karen E. ;

Black, Peter ;

Parker, Joel S. ;

Milowsky, Matthew I. ;

Hayes, D. Neil ;

Kim, William Y. .

JCO PRECISION ONCOLOGY, 2017, 1 :1-12

[7] Comprehensive somatic genome alterations of urachal carcinoma [J].

Lee, Seungchul ;

Lee, Jingu ;

Sim, Sung Hoon ;

Lee, Yeonghun ;

Moon, Kyung Chul ;

Lee, Cheol ;

Park, Woong-Yang ;

Kim, Nayoung K. D. ;

Lee, Se-Hoon ;

Lee, Hyunju .

JOURNAL OF MEDICAL GENETICS, 2017, 54 (08) :572-578

[8]

Modos O, 2015, Eur Urol Suppl, V14, pe1215

[9] Treatment of metastatic urachal carcinoma in an elderly woman [J].

Mohile, Supriya G. ;

Schleicher, Lori ;

Petrylak, Daniel P. .

NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (01) :55-58

[10] Predictors of survival from urachal cancer - A Mayo Clinic study of 49 cases [J].

Molina, Julian R. ;

Quevedo, J. Fernando ;

Furth, Alfred F. ;

Richardson, Ronald L. ;

Zincke, Horst ;

Burch, Patrick A. .

CANCER, 2007, 110 (11) :2434-2440

← 1 2 →